You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours (terminated appraisal)

  • Technology appraisal
  • Reference number: TA730
  • Published:  29 September 2021
  • Guidance
  • Tools and resources
  • History

On this page

  1. Draft guidance
  2. Invitation to participate
  3. Notes
  4. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

History

Documents created during the development process.

Draft guidance

  • Draft guidance

  • Appraisal consultation document (online commenting)

  • Appraisal consultation document (PDF version) (PDF 259 KB)

    Published:
    27 October 2020
  • Committee papers (PDF 2.24 MB)

    Published:
    27 October 2020
  • Public committee slides (PDF 1.43 MB)

    Published:
    27 October 2020

Invitation to participate

  • Final scope (PDF 190 KB)

    Published:
    19 February 2020
  • Final stakeholder list (PDF 195 KB)

    Published:
    19 February 2020
  • Draft scope and provisional stakeholder list comments table (post-referral) (PDF 292 KB)

    Published:
    19 February 2020
  • Equality impact assessment (Scoping) (PDF 124 KB)

    Published:
    19 February 2020

Notes

  • Note

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

  • Draft scope post referral (PDF 254 KB)

    Published:
    07 August 2019
  • Draft matrix post referral (PDF 186 KB)

    Published:
    07 August 2019
Back to top